DUBLIN–(BUSINESS WIRE)–The “Drug of Abuse Testing Services Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use; By Regions; Segment Forecast, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering.
The global drug of abuse testing services market size is expected to reach USD 4.08 billion by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
Several governments across the globe are initiating strict policy guidelines to contain drug abuse cases in the market. In this direction, the National Drug Control Budget requested an amount of USD 34.6 billion in the last financial year across five areas such as law enforcement, prevention & testing, operation, treatment, and interdiction.
It includes a grant of USD 1.9 billion for the Substance Abuse and Mental Health Services Administration for funding of evidence-based prevention initiatives and services. Department of Defense also requested more than USD 1.2 billion to monitor and support drug interdiction to counter-drug operations on the US soil.
Accessibility of the abuse testing services to the limited number of people with substance use across the market, with only being 1 in 7 cases being treated each year. However, in developed nations such as the US, there is a proper network and administration for reimbursement to treatment services to drug-related disorders. In line with this, the Centers for Medicare & Medicaid Services (CMS), in 2020, expanded its Medicare coverage to include medication-assisted treatment options in the opioid abuse testing and treatments scheduled.
Drug abusers among hard-working employees risk the business, they are involved in. To eliminate those risks, employers need to conduct regular abuse testing programs in the market, however, this is being a privacy issue in many countries. There are several key legislations, which are protecting the individual’s testing privacy rights.
Market participants operating in the drug of abuse testing services industry include Quest Diagnostics, United States Drug Testing Laboratories (USDTL), Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, DrugScan, Omega Laboratories, Inc., Legacy Medical Services, Psychemedics Corporation, Mayo Clinic Laboratories, Precision Diagnostics, Millennium Health, American Substance Abuse Professionals (ASAP), Inc., and LGC Group.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Drug of Abuse Testing Services Market Insights
4.1. Drug of Abuse Testing Services – Industry snapshot
4.2. Drug of Abuse Testing Services Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Drug of Abuse Testing Services Market Industry trends
5. Drug of Abuse Testing Services Market Assessment by Drug Type
5.1. Key Findings
5.2. Introduction
5.3. Alcohol
5.4. Cannabis/Marijuana
5.5. Cocaine
5.6. Opioids
5.7. Amphetamine & Methamphetamine
5.8. LSD
5.9. Others
6. Global Drug of Abuse Testing Services Market, by End Use
6.1. Key Findings
6.2. Introduction
6.3. Government
6.4. Private
6.5. Specialty Centers
7. Drug of Abuse Testing Services Market Assessment by Geography
7.1. Key findings
7.2. Introduction
7.3. Drug of Abuse Testing Services Market – North America
7.4. Drug of Abuse Testing Services Market – Europe
7.5. Drug of Abuse Testing Services Market – Asia-Pacific
7.6. Drug of Abuse Testing Services Market – Middle East & Africa
7.7. Drug of Abuse Testing Services Market – Latin America
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Quest Diagnostics
9.2. Abbott Laboratories
9.3. Cordant Health Solutions
9.4. Legacy Medical Services
9.5. Omega Laboratories, Inc.
9.6. Psychemedics Corporation
9.7. Millennium Health
9.8. Mayo Clinic Laboratories
9.9. LGC Group
9.10. United States Drug Testing Laboratories, Inc. (USDTL)
9.11. American Substance Abuse Professionals, Inc.
9.12. Precision Diagnostics
9.13. DrugScan
9.14. Laboratory Corporation of America Holdings
9.15. Clinical Reference Laboratory, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/dbvqks
